Role of ZPR1 in Nucleic Acid Binding and Cancer (G8882)

Target Name: ZPR1

NCBI ID: G8882

ZPR1

Role of ZPR1 in Nucleic Acid Binding and Cancer

ZPR1 (Zinc Finger Nucleotide) is a molecular chaperone that plays an important role in the nucleic acid binding protein (Nucleotide Binding Proteins, NBPs) family. In humans, ZPR1 binds to chromatin and affects gene expression and cell cycle regulation. Mutations in ZPR1 can cause a variety of genetic diseases, including Down syndrome, intellectual and developmental disabilities, and more.

In recent years, researchers have conducted in-depth studies of ZPR1 to determine its possible use as a drug target or biomarker. In this article, we will explore the role of ZPR1, its potential as a drug target, and its use as a biomarker.

The role of ZPR1

ZPR1 is an NBP that binds to specific locations on DNA. By binding to DNA, ZPR1 can influence gene expression and cell cycle regulation. ZPR1 functions in different stages of the cell cycle, including G1, S and G2 phases. During the G1 phase, ZPR1 binds to DNA and promotes DNA replication and gene expression. During S phase, ZPR1 binds to DNA and participates in DNA packaging and compaction. During the G2 phase, ZPR1 binds to DNA and participates in cell preparation for mitosis.

The role of ZPR1 in tumors

Mutations in ZPR1 can lead to tumorigenesis. Studies have found that ZPR1 mutations are closely related to the occurrence and development of various tumors. For example, mutations in ZPR1 are associated with an increased risk of tumors such as leukemia, colon cancer, and lung cancer. In addition, ZPR1 mutations are also associated with enhanced tumor invasion and metastasis capabilities.

Possibility of drug target for ZPR1

Mutations in ZPR1 can cause a variety of genetic diseases, including Down syndrome, intellectual and developmental disabilities, and more. Therefore, ZPR1 may be a potential drug target. Currently, researchers are exploring ZPR1's interactions with drugs to determine its potential as a drug target.

Biomarker applications of ZPR1

ZPR1 can be used as a biomarker to detect the incidence of certain diseases. For example, drugs that bind to ZPR1 could be used to test cancer patients' response to treatment. In addition, the concentration of ZPR1 can be used as a monitoring indicator of the effect of tumor treatment.

Development and clinical application of ZPR1

Currently, the development and clinical application of ZPR1 are continuing. Researchers are exploring ZPR1's potential as a drug target and exploring its use as a biomarker. Some studies have demonstrated ZPR1's interactions with drugs, but these studies have not proven ZPR1's safety and effectiveness. Therefore, these studies still need further confirmation.

in conclusion

ZPR1 is an NBP that plays an important role in the nucleic acid binding protein family. Its mutations can cause a variety of genetic diseases, including Down syndrome, intellectual and developmental disabilities, and more. In recent years, researchers have conducted in-depth studies of ZPR1 to determine its possible use as a drug target or biomarker. Currently, the development and clinical application of ZPR1 continues, and researchers are exploring the potential of ZPR1 as a drug target and exploring its application as a biomarker.

Protein Name: ZPR1 Zinc Finger

Functions: Acts as a signaling molecule that communicates proliferative growth signals from the cytoplasm to the nucleus. It is involved in the positive regulation of cell cycle progression (PubMed:29851065). Plays a role for the localization and accumulation of the survival motor neuron protein SMN1 in sub-nuclear bodies, including gems and Cajal bodies. Induces neuron differentiation and stimulates axonal growth and formation of growth cone in spinal cord motor neurons. Plays a role in the splicing of cellular pre-mRNAs. May be involved in H(2)O(2)-induced neuronal cell death

The "ZPR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZPR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets